Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
32,915
Sort by:
Global Vitamin C Market 2021 - Industry Statistics
US$ 750.00
Vitamin C, also known as L-ascorbic acid, is a water-soluble vitamin that is naturally present in some foods, added to others, and available as a dietary supplement. Humans, unlike most animals, are u...
December 2021
70 pages
Global Vitamins Market 2021 - Industry Statistics
US$ 2,800.00
Vitamins are organic substances present in minute amounts in natural foodstuffs. It is an essential micronutrient which an organism needs in small quantities for the proper functioning of its metaboli...
December 2021
88 pages
Global Vitamin B1 Market 2021 - Industry Statistics
US$ 750.00
Vitamin B1, or thiamin (thiamine), is a water-soluble vitamin found naturally in some foods, added to foods, and sold as a supplement. Vitamin B1 plays a vital role in the growth and function of vario...
December 2021
63 pages
Global Vitamin B12 Market 2021 - Industry Statistics
US$ 750.00
Vitamin B12 is an important B vitamin. It is crucial for nerve tissue health, brain function, and the production of red blood cells. The global vitamin B12 market is projected to expand at a CAGR of ~...
December 2021
62 pages
Global Vitamin B6 Market 2021 - Industry Statistics
US$ 750.00
Vitamin B6, or pyridoxine, is a water-soluble vitamin found naturally in many foods, as well as added to foods and supplements. According to latest analysis by Gen Consulting Company, the global vitam...
December 2021
61 pages
Global Vitamin B7 Market 2021 - Industry Statistics
US$ 750.00
Vitamin B7, also known as biotin, vitamin H, is a water-soluble vitamin that helps the body metabolize fats, carbohydrates, and protein. Vitamin B7 supplements are often glamorized as a treatment for...
December 2021
73 pages
Global Vitamin B9 Market 2021 - Industry Statistics
US$ 750.00
Vitamin B9, also called folate or folic acid, is one of 8 B vitamins. All B vitamins help the body convert food (carbohydrates) into fuel (glucose), which is used to produce energy. According to marke...
December 2021
60 pages
Global Vitamin B2 Market 2021 - Industry Statistics
US$ 750.00
Vitamin B2, or riboflavin, is one of eight B vitamins that are essential for human health. It is essential to the formation of two major coenzymes, flavin mononucleotide and flavin adenine dinucleotid...
December 2021
72 pages
Global Vitamin D3 Market 2021 - Industry Statistics
US$ 750.00
Vitamin D helps regulate the amount of calcium and phosphate in the body. These nutrients are needed to keep bones, teeth and muscles healthy. In humans, the most important compounds in this group are...
December 2021
65 pages
Global Vitamin E Market 2021 - Industry Statistics
US$ 750.00
Vitamin E is a group of eight fat soluble compounds that include four tocopherols and four tocotrienols. Vitamin E helps maintain healthy skin and eyes, and strengthen the body's natural defence again...
December 2021
66 pages
Global Over the Counter (OTC) Drugs Market, By Product (Cough, Cold & Flu, Vitamins, Mineral, & Supplements (VMS), Analgesics, Gastrointestinal Products, Dermatology Products, Others), By Route of Administration (Oral, Parenteral, Topical, Others), By Dosage Form (Tablets, Capsules, Liquids & Solutions, Cream/Lotion/Ointments, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition, Forecast & Opportunities, 2026
US$ 4,900.00
Global Over the Counter (OTC) drugs market is anticipated to grow at CAGR of 9.86% through 2026 to reach USD274.15 billion by the end of forecast period, 2026. Future growth of the global over the cou...
December 2021
115 pages
United States Generic Drugs Market, By Type (Small Molecule Generics v/s Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Infectious Diseases, Others), By Mode of Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House v/s Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Region, Competition, Forecast and Opportunity, 2026
US$ 4,400.00
United States generic drugs market was valued USD70.78 billion in 2020 and is forecast to grow at CAGR of 9.43% during the forecast period and may achieve market value of USD126.74 billion by the year...
December 2021
75 pages
Asia Pacific Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity
US$ 2,295.00
Asia Pacific drug discovery market will grow by 10.6% annually with a total addressable market cap of $231.8 billion over 2021-2030 owing the rising demand for specialty medicines, the surge in lifest...
November 2021
120 pages
Asia Pacific Injectable Drugs Market 2020-2030 by Molecule Type (Small, Large), Drug Class (mAbs, Immunoglobulin, Insulin, Vaccines, Cytokines, Peptide Hormone, Blood Factors), Delivery (Pre-filled Syringe, Infusions, Others), Application (Oncology, Infectious Diseases, Autoimmune, Cardiovascular), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce), and Country: Trend Forecast and Growth Opportunity
US$ 2,125.00
Asia Pacific injectable drugs market will grow by 13.0% annually with a total addressable market cap of $2,165.4 billion over 2021-2030 owing to the increasing prevalence of chronic diseases, rising u...
November 2021
109 pages
Europe Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity
US$ 2,295.00
Europe drug discovery market was valued at $14.8 billion in 2020 and will grow by 8.3% annually over 2020-2030 owing the rising demand for specialty medicines, the surge in lifestyle-oriented diseases...
November 2021
123 pages
Europe Injectable Drugs Market 2020-2030 by Molecule Type (Small, Large), Drug Class (mAbs, Immunoglobulin, Insulin, Vaccines, Cytokines, Peptide Hormone, Blood Factors), Delivery (Pre-filled Syringe, Infusions, Others), Application (Oncology, Infectious Diseases, Autoimmune, Cardiovascular), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce), and Country: Trend Forecast and Growth Opportunity
US$ 2,125.00
Europe injectable drugs market was valued at $104.8 billion in 2020 and will grow by 9.7% annually over 2020-2030 owing to the increasing prevalence of chronic diseases, rising use of self-administere...
November 2021
111 pages
Global Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Region: Trend Forecast and Growth Opportunity
US$ 2,720.00
Global drug discovery market will reach $117.6 billion by 2030, growing by 8.6% annually over 2020-2030 driven by the rising demand for specialty medicines, the surge in lifestyle-oriented diseases an...
November 2021
181 pages
Global Injectable Drugs Market 2020-2030 by Molecule Type (Small, Large), Drug Class (mAbs, Immunoglobulin, Insulin, Vaccines, Cytokines, Peptide Hormone, Blood Factors), Delivery (Pre-filled Syringe, Infusions, Others), Application (Oncology, Infectious Diseases, Autoimmune, Cardiovascular), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce), and Region: Trend Forecast and Growth Opportunity
US$ 2,465.00
Global injectable drugs market will reach $1,037.7 billion by 2030, growing by 9.8% annually over 2020-2030 driven by the increasing prevalence of chronic diseases, rising use of self-administered Inj...
November 2021
165 pages
North America Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity
US$ 2,295.00
North America drug discovery market is expected to grow by 7.9% annually in the forecast period and reach $41.44 billion by 2030 driven by the rising demand for specialty medicines, the surge in lifes...
November 2021
117 pages
North America Injectable Drugs Market 2020-2030 by Molecule Type (Small, Large), Drug Class (mAbs, Immunoglobulin, Insulin, Vaccines, Cytokines, Peptide Hormone, Blood Factors), Delivery (Pre-filled Syringe, Infusions, Others), Application (Oncology, Infectious Diseases, Autoimmune, Cardiovascular), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce), and Country: Trend Forecast and Growth Opportunity
US$ 2,125.00
North America injectable drugs market is expected to grow by 8.3% annually in the forecast period and reach $372.9 billion by 2030 driven by the increasing prevalence of chronic diseases, rising use o...
November 2021
102 pages
Bladder Cancer (Oncology) - Drugs in Development, 2021
US$ 2,500.00
Bladder Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer - Drugs In Development, 2021, provides...
November 2021
2564 pages
Gaucher Disease - Drugs in Development, 2021
US$ 2,000.00
Gaucher Disease - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gaucher Disease - Drugs In Development, 2021, provides an overv...
November 2021
143 pages
Hypertension (Cardiovascular) - Drugs in Development, 2021
US$ 2,500.00
Hypertension (Cardiovascular) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypertension - Drugs In Development, 2021, provid...
November 2021
872 pages
Keloids (Dermatology) - Drugs in Development, 2021
US$ 2,000.00
Keloids (Dermatology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Keloids - Drugs In Development, 2021, provides an overvie...
November 2021
51 pages
Macular Edema (Ophthalmology) - Drugs in Development, 2021
US$ 2,000.00
Macular Edema (Ophthalmology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Macular Edema - Drugs In Development, 2021, provi...
November 2021
102 pages
Melanoma (Oncology) - Drugs in Development, 2021
US$ 2,500.00
Melanoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Melanoma - Drugs In Development, 2021, provides an overview...
November 2021
4610 pages
